Clinical Trial Update: Impact of High-dose Pretreatment of Rosuvastatin in Patients With Acute Coronary Syndrome Following Off-pump Coronary Artery Bypass: Results From the HIROP-ACS (HIgh-dose Pretreatment of Rosuvastatin During Off-Pump Coronary Bypass in Acute Coronary Syndrome) Study [Phase 4]

View source ↗

Summary

This report summarizes the results of HIROP-ACS, a Phase 4 trial evaluating high-dose pretreatment with rosuvastatin in patients with acute coronary syndrome un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Yonsei University | Conditions: A Total of 234 Patients With Acute Coronary Syndrome Who Will Undergo OPCAB. | Phase 4 | Status: COMPLETED